Boxer Capital’s Immunomedics Inc IMMU Stock Holding History

Boxer Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,500,000	Closed	-$383M	–	91
2020 Q3	$383M	Sell	4,500,000 -2,106,000	-32%	-$107M	13.22%	1
2020 Q2	$234M	Sell	6,606,000 -1,844,000	-22%	-$53.9M	10.29%	1
2020 Q1	$114M	Hold	8,450,000	–	–	7.76%	2
2019 Q4	$179M	Buy	8,450,000 +1,500,000	+22%	+$26.5M	10.11%	2
2019 Q3	$92.2M	Buy	6,950,000 +383,000	+6%	+$5.63M	6.68%	4
2019 Q2	$91.1M	Buy	6,567,000 +2,467,000	+60%	+$37.1M	7.83%	4
2019 Q1	$78.8M	Buy	4,100,000 +2,950,000	+257%	+$47.5M	9.11%	3
2018 Q4	$16.4M	Buy	+1,150,000	New	+$22.8M	2.03%	15

Boxer Capital's IMMU Position: Q4 2020 in Review

Boxer Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,500,000 shares — an estimated $383M sold.

Boxer Capital first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $383M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Boxer Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Boxer Capital sold 4,500,000 Immunomedics Inc shares in Q4 2020, an estimated $383M.
Boxer Capital first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
Boxer Capital's Immunomedics Inc position peaked at $383M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Boxer Capital's 13F filing for Q4 2020, filed 16 Feb 2021.